Johan Vansteenkiste: A lifelong commitment to improving outcomes in thoracic oncology

Ensuring Quality of Life During Lung Cancer Survivorship Requires a Multidisciplinary Team

COVID-19 and Lung Cancer: A Call for Immediate Action

A Clinical Trial of PD-L1 Inhibitor Durvalumab and PARP Inhibitor Olaparib for Patients With EGFR-Mutated Transformed SCLC

Mitigating Pain in Thoracic Surgery

The Dandelion Dilemma of Brain Metastases: Treating the Whole Lawn or the Weeds Separately

New IASLC Grading System for Pulmonary Adenocarcinoma Proposed

Brendon Stiles, MD

PET vs. CT in Lung Cancer Surveillance: The ‘Pro’ Side from the Nuclear Medicine Perspective

Patient Perspectives on CT and PET Scans: Imaging Technology Provides Different Benefits, Drawbacks for Each Individual Patient

Mutation or Amplification: Who MET the Expectations?

Large LDCT Lung Cancer Screening Program Suggests Screening Benefits Far Outweigh the Risks